Abstract
Candida glabrata is an important human pathogen, and an understanding of the genetic relatedness of its clinical isolates is essential for the prevention and control of fungal infections. In this study, we determined the relatedness of 38 Candida glabrata clinical isolates originating from two teaching hospitals in Slovakia. The 14 different genotypes were found by using microsatellite marker analysis (RPM2, MTI and Cg6) and DNA sequencing for analysis of the entire ERG11 gene. Subsequent sequencing of amplified DNA fragments of the PDR1, NMT1, TRP1 and URA3 loci in ten selected clinical isolates revealed identical DNA sequence profiles in five of them. They displayed the same microsatellite marker sizes and contained the same H576Y amino acid substitution recently described in the Pdr1p multidrug resistance transcription factor responsible for azole resistance. These results demonstrate the genetic diversity of C. glabrata clinical isolates in our hospitals and indicate a common clonal origin of some drug resistant ones.
Similar content being viewed by others
References
Pfaller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis. 1999;33:217–22.
Diekema DJ, Messer SA, Brueggemann AB, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol. 2002;40:1298–302.
Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: results of 28 month European confederation of medical mycology (ECMM) hospital based surveillance study. Eur J Clin Microbiol Infect Dis. 2004;23:317–22.
Sobel JD, Chain W. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis. 1997;24:649–52.
Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351:876–83.
Sojakova M, Liptajova D, Borovsky M, Subik J. Fluconazole and itraconazole susceptibility of vaginal isolates from Slovakia. Mycopathologia. 2004;157:163–9.
Bialkova A, Subik J. Biology of the pathogenic yeast Candida glabrata. Folia Microbiol. 2006;51:3–20.
Kaur R, Domerque E, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol. 2005;8:378–84.
Sanglard D. Genomic view on antifungal resistance mechanisms among yeast and fungal pathogens. In: d‘Enfert Ch, Hube B, editors. Candida: comparative and functional genomics. Norfolk: Caister Academic Press; 2007. p. 359–82.
Berila N, Borecka S, Dzugasova V, Bojnansky J, Subik J. Mutations in CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia. Int J Antimicrob Agents. 2009;33:574–8.
Dassanayake RS, Samaranayake LP. Amplification-based nucleic acid scanning techniques to assess genetic polymorphism in Candida. Crit Rev Microbiol. 2003;29:1–24.
Abbes S, Amouri I, Sellami H, Sellami A, Makni F, Ayadi A. A review of molecular techniques to type Candida glabrata isolates. Mycoses. 2010. doi:10.1111/j.1439-0507.2009.01753.x.
Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol. 2003;41:5709–17.
Lin CY, Chen YC, Lo HJ, Chen KW, Li SY. Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol. 2007;45:2452–9.
Shin JH, Chae MJ, Song JW, et al. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia. J Clin Microbiol. 2007;45:2385–91.
Foulet F, Nicolas N, Eloy O, et al. Microsatellite marker analysis as a typing system of Candida glabrata. J Clin Microbiol. 2005;43:4574–9.
Grenouilllet F, Millon L, Bart JM, et al. Multiple-locus variable-number tandem-repeat analysis for rapid typing of Candida glabrata. J Clin Microbiol. 2007;45:3781–4.
Xu J, Ramos A, Vilgalys R, Mitchel TG. Clonal and spontaneous origin of fluconazole resistance in Candida albicans. J Clin Microbiol. 2000;38:1214–20.
Cernicka J, Subik J. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. Int J Antimicrob Agents. 2006;27:403–8.
Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, et al. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 2009;5(1):e1000268.
Acknowledgments
We thank H. Drahovska for help with BioNumerics software and D. Hanson for careful reading of the manuscript. This work was supported by grants from the Slovak Research and Developmental Agency (LPP-0022-06, LPP-0011-07, VVCE-0064-07) and the Slovak Grant Agency of Science (VEGA 1/0001/09).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berila, N., Subik, J. Molecular analysis of Candida glabrata clinical isolates. Mycopathologia 170, 99–105 (2010). https://doi.org/10.1007/s11046-010-9298-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-010-9298-1